These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3026632

  • 1. [Leukotrienes--mediators of inflammation, ischemia and shock. Their significance in the pathogenesis of central nervous system diseases].
    Mayer M.
    Cas Lek Cesk; 1987 Jan 03; 126(1):15-8. PubMed ID: 3026632
    [No Abstract] [Full Text] [Related]

  • 2. Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders.
    Lefer AM.
    Prog Clin Biol Res; 1988 Jan 03; 264():101-14. PubMed ID: 2837782
    [Abstract] [Full Text] [Related]

  • 3. Eicosanoids as mediators of ischemia and shock.
    Lefer AM.
    Fed Proc; 1985 Feb 03; 44(2):275-80. PubMed ID: 2981745
    [Abstract] [Full Text] [Related]

  • 4. Leukotrienes as mediators of ischemia and shock.
    Lefer AM.
    Biochem Pharmacol; 1986 Jan 15; 35(2):123-7. PubMed ID: 3002383
    [Abstract] [Full Text] [Related]

  • 5. Leukotrienes: a new class of mediators of immediate hypersensitivity reactions and inflammation.
    Samuelsson B.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Jan 15; 11():1-13. PubMed ID: 6303067
    [No Abstract] [Full Text] [Related]

  • 6. A. N. Richards lecture. Leukotrienes: possible mediators of disease.
    Piper PJ.
    Prog Clin Biol Res; 1985 Jan 15; 199():1-11. PubMed ID: 2999816
    [No Abstract] [Full Text] [Related]

  • 7. Leukotrienes and prostaglandins in the immune system.
    Parker CW.
    Adv Prostaglandin Thromboxane Leukot Res; 1986 Jan 15; 16():113-34. PubMed ID: 3028091
    [No Abstract] [Full Text] [Related]

  • 8. Understanding leukotrienes.
    Wardle N.
    Br J Hosp Med; 1986 Jun 15; 35(6):382, 384, 386-7. PubMed ID: 3013352
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Leukocyte recognition and metabolism of leukotrienes.
    Goetzl EJ.
    Fed Proc; 1983 Nov 15; 42(14):3128-31. PubMed ID: 6313435
    [Abstract] [Full Text] [Related]

  • 17. Biology of the leukotrienes.
    Ann N Y Acad Sci; 1988 Nov 15; 524():xi-xxv, 1-475. PubMed ID: 2837947
    [No Abstract] [Full Text] [Related]

  • 18. [Leukotrienes and other lipoxygenase derivatives: a group of pharmacologically very active lipid mediators].
    Maclouf J, Mencia-Huerta JM.
    Pathol Biol (Paris); 1985 Jan 15; 33(1):5-8. PubMed ID: 2983287
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Leukotrienes and prostanoids in health and disease.
    Adv Prostaglandin Thromboxane Leukot Res; 1986 Jan 15; 16():3-405. PubMed ID: 3028099
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.